Madiha Khurshid

Title: Madiha Khurshid: Innovator in Antibody Glycoform Modulation

Introduction

Madiha Khurshid is a prominent inventor based in Thousand Oaks, CA (US). She has made significant contributions to the field of biotechnology, particularly in the modulation of glycoforms of antibodies. Her innovative work has led to the development of methods that enhance the production of glycosylated proteins in cell cultures.

Latest Patents

Madiha holds a patent titled "Control of total afucosylated glycoforms of antibodies produced in cell culture." This patent outlines methods for modulating the levels of total afucosylated (TAF) glycoforms of recombinant glycosylated proteins produced by glycosylation-competent cells. The methods involve maintaining the cell culture at an initial set point pH for a specified period. Additionally, the patent includes related compositions comprising glycosylated proteins and TAF glycoforms.

Career Highlights

Madiha is currently employed at Amgen Inc., a leading biotechnology company known for its innovative therapies. Her work at Amgen has allowed her to apply her expertise in glycoform modulation to real-world applications, contributing to advancements in therapeutic antibody production.

Collaborations

Madiha has collaborated with notable colleagues, including Chung-Jr Huang and Prince Bhebe. These collaborations have fostered a productive environment for innovation and research within her field.

Conclusion

Madiha Khurshid is a trailblazer in the biotechnology sector, with her patent on glycoform modulation showcasing her innovative spirit. Her contributions continue to impact the development of therapeutic antibodies, highlighting her role as a key inventor in this vital area of research.